JANX - Janux Therapeutics GAAP EPS of -$0.42 revenue of $1.05M August, 09 2023 01:06 PM Janux Therapeutics Inc. 2023-08-09 13:06:36 ET Janux Therapeutics press release ( NASDAQ: JANX ): Q2 GAAP EPS of -$0.42. Revenue of $1.05M (-55.5% Y/Y). For further details see: Janux Therapeutics GAAP EPS of -$0.42, revenue of $1.05M